Reply: (99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours

por Koukourakis, M I
Publicado 2002

p53 and angiogenesis in non-small-cell lung cancer.

por Giatromanolaki, A., Koukourakis, M. I.
Publicado 1998

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?

por Koukourakis, M I, Giatromanolaki, A, Galazios, G, Sivridis, E
Publicado 2003

Human Papillomavirus in Endometrial Adenocarcinomas: Infectious Agent or a Mere “Passenger”?

por Giatromanolaki, A., Sivridis, E., Papazoglou, D., Koukourakis, M. I., Maltezos, E.
Publicado 2007

Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer

por Koukourakis, M I, Giatromanolaki, A, Tsakmaki, V, Danielidis, V, Sivridis, E
Publicado 2012

High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

por Koukourakis, M I, Koukouraki, S, Fezoulidis, I, Kelekis, N, Kyrias, G, Archimandritis, S, Karkavitsas, N
Publicado 2000

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy

por Koukourakis, M I, Giatromanolaki, A, Panteliadou, M, Pouliliou, S E, Chondrou, P S, Mavropoulou, S, Sivridis, E
Publicado 2014

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis

por Sivridis, E, Giatromanolaki, A, Papadopoulos, I, Gatter, K C, Harris, A L, Koukourakis, M I
Publicado 2002

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia

por Koukourakis, M I, Giatromanolaki, A, Sivridis, E, Pitiakoudis, M, Gatter, K C, Harris, A L
Publicado 2010

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cy...

por Koukourakis, M I, Romanidis, K, Froudarakis, M, Kyrgias, G, Koukourakis, G V, Retalis, G, Bahlitzanakis, N
Publicado 2002

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

por Koukourakis, M I, Giatromanolaki, A, Sivridis, E, Bougioukas, G, Didilis, V, Gatter, K C, Harris, A L
Publicado 2003

Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance.

por Kaklamanis, L., Koukourakis, M. I., Leek, R., Giatromanolaki, A., Ritter, M., Whitehouse, R., Gatter, K. C., Harris, A. L.
Publicado 1996

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

por Giatromanolaki, A, Koukourakis, M I, Sivridis, E, Turley, H, Talks, K, Pezzella, F, Gatter, K C, Harris, A L
Publicado 2001

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.

por Koukourakis, M. I., Giatromanolaki, A., Kakolyris, S., O'Byrne, K. J., Apostolikas, N., Skarlatos, J., Gatter, K. C., Harris, A. L.
Publicado 1998

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

por O'Byrne, K J, Koukourakis, M I, Giatromanolaki, A, Cox, G, Turley, H, Steward, W P, Gatter, K, Harris, A L
Publicado 2000

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

por Koukourakis, M I, Bahlitzanakis, N, Froudarakis, M, Giatromanolaki, A, Georgoulias, V, Koumiotaki, S, Christodoulou, M, Kyrias, G, Skarlatos, J, Kostantelos, J, Beroukas, K
Publicado 1999

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

por Koukourakis, M. I., Giatromanolaki, A., O'Byrne, K. J., Comley, M., Whitehouse, R. M., Talbot, D. C., Gatter, K. C., Harris, A. L.
Publicado 1997

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.

por O'Byrne, K. J., Koukourakis, M. I., Saunders, M. P., Salisbury, A. J., Isaacs, R., Varcoe, S., Taylor, M., Ganesan, T. S., Harris, A. L., Talbot, D. C.
Publicado 1998

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

por Giatromanolaki, A, Koukourakis, M I, Sivridis, E, Gatter, K C, Trarbach, T, Folprecht, G, Shi, M M, Lebwohl, D, Jalava, T, Laurent, D, Meinhardt, G, Harris, A L
Publicado 2012

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

por O'Byrne, K J, Dobbs, N, Propper, D J, Braybrooke, J P, Koukourakis, M I, Mitchell, K, Woodhull, J, Talbot, D C, Schally, A V, Harris, A L
Publicado 1999